Skip to main content
. Author manuscript; available in PMC: 2020 Oct 1.
Published in final edited form as: DNA Repair (Amst). 2019 Aug 30;82:102697. doi: 10.1016/j.dnarep.2019.102697

Figure 5:

Figure 5:

Exogenous XPF expression in MDA-MB-468 cells rescues NER deficiency and cisplatin sensitivity. A. Immunoblot showing stable expression of wild-type XPF in MDA-MB-468 cells. B. XPF expression rescues NER deficiency in the DDB2 proteo-probe assay (**p<0.01). C. XPF expression rescues cisplatin sensitivity of the MDA-MB-468 cell line. D. XPF expression does not impact sensitivity to the PARP inhibitor olaparib. EV: empty vector.